Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 years - Lublin, Fred D.; Cofield, Stacey S.; Cutter, Gary R.; Gustafson, Tarah; Krieger, Stephen; Narayana, Ponnada A.; Nelson, Flavia; Salter, Amber R.; Wolinsky, Jerry S. (Multiple sclerosis and related disorders, 2017)
Keywords: Clinical trial; Disease activity free status; Glatiramer acetate; Interferon beta-1a; RRMS; RRMS; Glatiramer acetate; Clinical trial; Disease activity free status; Interferon beta-1a